Answers are grounded in this paper and cite their sources.
DPP4 inhibitors are effective at reducing the circulating postprandial glucagon level in T2DM patients.
No takes yet. Share an insight, caveat, or question.
Chai et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: